Proteon Therapeutics Inc. (PRTO)

0.32
NASDAQ : Health Technology
Prev Close 0.33
Day Low/High 0.32 / 0.33
52 Wk Low/High 0.27 / 3.94
Avg Volume 1.00M
Exchange NASDAQ
Shares Outstanding 19.59M
Market Cap 6.46M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Proteon Therapeutics Completes Enrollment In PATENCY-2, Phase 3 Clinical Trial Of Investigational Vonapanitase

Proteon Therapeutics Completes Enrollment In PATENCY-2, Phase 3 Clinical Trial Of Investigational Vonapanitase

- Top-line data from PATENCY-2 expected in March of 2019 -

PRTO Crosses Above Average Analyst Target

PRTO Crosses Above Average Analyst Target

In recent trading, shares of Proteon Therapeutics Inc have crossed above the average analyst 12-month target price of $2.43, changing hands for $2.50/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Proteon Therapeutics Announces $22.0 Million Private Placement

Provides Sufficient Cash into Q4 2019

Biotech Movers: Depomed Shares Tank After Losses Get Even Worse

Biotech Movers: Depomed Shares Tank After Losses Get Even Worse

Depomed unveiled steps the company is taking to shore itself up.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.